Gastritis

An authoritative clinical profile of Gastritis covering ACG 2021 diagnostic guidelines, H. pylori vs NSAID-induced etiologies, upper GI hemorrhage emergency red flags, and endoscopy non-delay boundaries.

Editorial review complete

Independent clinical validation is pending.

Validation pending

Quick Reference Facts

System AffinityGastrointestinal
Diagnostic StandardClinical evaluation & serum biomarkers
Urgency Levelroutine
Evidence GradeConsensus-Guidance

In simple words

Gastritis is defined as inflammation of the gastric mucosal lining confirmed histologically or endoscopically [D0008-KEYNOTES, CIT-0044]. It ranges from acute erosive hemorrhagic gastropathy to chronic Helicobacter pylori or autoimmune gastritis.

What it means

A histologically or endoscopically documented inflammatory mucosal breakdown of the stomach wall induced by bacterial infection, chemical irritants, or autoantibodies.

Common causes

  • Helicobacter pylori bacterial colonization causing chronic antral or pangastritis [D0008-KEYNOTES, CIT-0044]
  • Chronic nonsteroidal anti-inflammatory drug (NSAID) or aspirin use disrupting protective mucosal prostaglandins
  • Excessive alcohol intake, heavy smoking, severe physiological stress (stress ulcers), or autoimmune parietal cell antibodies

Risk Factors

  • Frequent or unmonitored use of NSAIDs, corticosteroids, or anticoagulants
  • Untreated H. pylori infection, chronic alcohol ingestion, and high physiological stress
  • Autoimmune conditions (e.g. Hashimoto's thyroiditis, Type 1 diabetes) predisposing to autoimmune gastritis

Common symptoms

  • Epigastric gnawing or burning pain, early satiety, postprandial fullness, and nausea [D0008-KEYNOTES, CIT-0044]
  • Abdominal distension, belching, regurgitation, and anorexia
  • Erosive gastropathy symptoms: Occult blood loss, microcytic anemia, or hematemesis

Lifestyle & diet support

Avoid NSAIDs, alcohol, smoking, and highly spiced or greasy foods; eat small, regular meals; maintain adequate hydration; and manage chronic stress.

Treatment Approaches

Conventional Management

Management involves proton pump inhibitors (PPIs), H2-receptor antagonists, sucralfate mucosal protectants, discontinuing offending NSAIDs, and quad-therapy antibiotic regimens for H. pylori eradication [CIT-0044].

Homeopathic Approach

Homeopathic remedies (such as Nux Vomica, Arsenicum Album, Phosphorus, Lycopodium) act as supportive care to soothe burning epigastric discomfort, balance digestive acidity, and improve dietary tolerance alongside gastroenterological evaluation.

Frequently Asked Questions

Hematemesis (vomiting frank blood or 'coffee-ground' material), melena (black tarry stools), acute severe epigastric agony, dizziness with hypotension, or persistent uncontrollable vomiting indicates ACUTE UPPER GI HEMORRHAGE OR PERFORATION [D0008-EMERGENCY-LIMITS, CIT-0044]. This is a MEDICAL EMERGENCY requiring IMMEDIATE ER evaluation.
NO. Homeopathy MUST NOT be used to replace diagnostic upper endoscopy in red-flag cases or delay prescribed antibiotic eradication therapy for H. pylori infection [D0008-REGULATORY-LIMITS]. Untreated H. pylori carries risks of peptic ulceration and gastric MALT lymphoma.
Homeopathy provides supportive constitutional care for symptomatic relief while patients remain under standard gastroenterology diagnostic and monitoring protocols [D0008-REGULATORY-LIMITS].
Clinical & academic detailShow detail

Diagnosis & tests

Investigation Protocol

Diagnosed via Esophagogastroduodenoscopy (EGD) with mucosal biopsy, H. pylori urea breath test or stool antigen assay, and serum anti-parietal cell antibody panels [CIT-0044].

Differential Diagnosis

Differentiate Gastritis from Peptic Ulcer Disease (PUD), GERD, Functional Dyspepsia, Cholecystitis, Pancreatitis, and Gastric Adenocarcinoma.

Differential Diagnosis Matrix

Differential Diagnosis Overview

Differentiate Gastritis from Peptic Ulcer Disease (PUD), GERD, Functional Dyspepsia, Cholecystitis, Pancreatitis, and Gastric Adenocarcinoma.

Reference Citations & Evidence Sources

Clinical Guidelines & Consensus Statements
  • CIT-0017NICE. "Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management." NICE Clinical Guideline CG184 (2014).
  • CIT-0018NICE. "Irritable Bowel Syndrome in Adults: Diagnosis and Management." NICE Guideline CG61 (2008).
  • CIT-0044Chey W. D., Leontiadis G. I., Howden C. W.. "ACG Clinical Guideline: Treatment of Helicobacter pylori Infection and Gastritis Management." American Journal of Gastroenterology (2021).DOI PubMed
Clinical Reviews & Textbooks
  • CIT-0022Jethwani N.. "Internal Clinical Review Note: Standard Reference Values and Homeopathic Therapeutic Mappings for Lab Diagnostics." Homeo Healthcare Internal Review Series (2026).

Clinical Connections

Related Comparisons

Medical Safety Disclaimer

All content on the Homeo Healthcare platform is strictly for educational purposes and is not personal medical advice, diagnosis, or treatment. Homeopathic remedy considerations are provided for clinician review or require individualized consultation with a qualified physician. Never delay seeking professional medical advice or emergency medical care due to content you have read on this website.